The U.S. Food and Drug Administration (FDA) today (March 30) issued a temporary guidance intended to expand the availability of surgical apparel for healthcare professionals, including gowns (togas), hoods, and […]
Dartmouth-Hitchcock Health just helped open two Phase III COVID-19–related therapeutic studies in six business days. The Gilead-sponsored studies, one of patients with moderate COVID-19 and the other with patients suffering more serious symptoms, are evaluating the safety and antiviral activity of Remdesivir (GS-5734™) against the condition.
The U.S. Food and Drug Administration (FDA) has issued a guidance authorizing the emergency use of ventilators, anesthesia gas machines modified for use as ventilators, and positive pressure breathing devices […]
From movie theaters to restaurants to shopping malls, coronavirus-inspired closures are already impacting the national economy in significantly negative ways. The same phenomenon appears to be damaging clinical trials, says […]
Lung cancer clinical trials supported by the pharmaceutical industry demonstrate no more bias than studies funded by other sources, according to a recent study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.